ARTICLE | Company News
ProScript other research news
January 11, 1999 8:00 AM UTC
ProScript entered into a CRADA with the National Cancer Institute (NCI) to develop the company's PS-341, currently in Phase I development. The NCI will sponsor additional Phase I trials for the compou...